Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 3 | 2023 | 120 | 1.650 |
Why?
|
| HIV Integrase Inhibitors | 3 | 2023 | 142 | 1.560 |
Why?
|
| HIV Reverse Transcriptase | 4 | 2014 | 213 | 1.370 |
Why?
|
| Drug Resistance, Viral | 9 | 2023 | 820 | 1.270 |
Why?
|
| HIV-1 | 13 | 2023 | 6934 | 1.080 |
Why?
|
| Virus Replication | 6 | 2023 | 2531 | 0.540 |
Why?
|
| Pyrrolidinones | 2 | 2014 | 117 | 0.480 |
Why?
|
| Lamivudine | 2 | 2011 | 342 | 0.430 |
Why?
|
| HIV Infections | 12 | 2023 | 16678 | 0.420 |
Why?
|
| Reverse Transcriptase Inhibitors | 3 | 2014 | 615 | 0.370 |
Why?
|
| Pyridazines | 1 | 2011 | 201 | 0.350 |
Why?
|
| Anti-HIV Agents | 6 | 2021 | 4250 | 0.320 |
Why?
|
| Zidovudine | 1 | 2006 | 620 | 0.240 |
Why?
|
| Point Mutation | 2 | 2007 | 1624 | 0.240 |
Why?
|
| Amino Acid Substitution | 2 | 2023 | 1792 | 0.210 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2014 | 459 | 0.210 |
Why?
|
| Oxazines | 1 | 2023 | 298 | 0.210 |
Why?
|
| Pyridones | 1 | 2023 | 712 | 0.170 |
Why?
|
| Viral Load | 4 | 2018 | 3292 | 0.160 |
Why?
|
| Receptors, CCR5 | 3 | 2015 | 497 | 0.160 |
Why?
|
| HIV Long-Term Survivors | 1 | 2018 | 126 | 0.150 |
Why?
|
| Viremia | 2 | 2023 | 735 | 0.150 |
Why?
|
| Proviruses | 1 | 2018 | 316 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1723 | 0.130 |
Why?
|
| Alkynes | 1 | 2014 | 306 | 0.110 |
Why?
|
| Cyclopropanes | 1 | 2014 | 416 | 0.110 |
Why?
|
| Benzoxazines | 1 | 2014 | 301 | 0.110 |
Why?
|
| Mutation | 7 | 2023 | 29717 | 0.100 |
Why?
|
| Virion | 1 | 2014 | 433 | 0.100 |
Why?
|
| Pyrimidines | 3 | 2012 | 2933 | 0.100 |
Why?
|
| Virus Internalization | 2 | 2012 | 501 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 726 | 0.090 |
Why?
|
| Botswana | 2 | 2023 | 1040 | 0.090 |
Why?
|
| Reassortant Viruses | 1 | 2007 | 37 | 0.080 |
Why?
|
| Didanosine | 1 | 2007 | 153 | 0.080 |
Why?
|
| Dideoxynucleosides | 1 | 2007 | 122 | 0.070 |
Why?
|
| Nitriles | 1 | 2011 | 952 | 0.070 |
Why?
|
| Cell Line | 3 | 2012 | 15994 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 898 | 0.070 |
Why?
|
| Codon | 1 | 2007 | 611 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1835 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4200 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1871 | 0.060 |
Why?
|
| Piperazines | 2 | 2012 | 2488 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 4771 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1618 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2007 | 824 | 0.060 |
Why?
|
| Kinetics | 2 | 2011 | 6474 | 0.050 |
Why?
|
| Adenine | 1 | 2007 | 936 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2007 | 3127 | 0.050 |
Why?
|
| Humans | 14 | 2023 | 742088 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 2 | 2023 | 1712 | 0.040 |
Why?
|
| Defective Viruses | 1 | 2018 | 112 | 0.040 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 131 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13256 | 0.040 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2012 | 952 | 0.040 |
Why?
|
| HIV Antibodies | 1 | 2023 | 1320 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18112 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2007 | 2978 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 667 | 0.030 |
Why?
|
| Viral Tropism | 1 | 2014 | 101 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10943 | 0.030 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 222 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 1970 | 0.030 |
Why?
|
| Receptors, HIV | 1 | 2013 | 162 | 0.030 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 370 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2011 | 205 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 2479 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2014 | 1526 | 0.020 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2012 | 314 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 2557 | 0.020 |
Why?
|
| Amides | 1 | 2011 | 458 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3847 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12946 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2015 | 2899 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1937 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 2790 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 2751 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 2797 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 1872 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13814 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5095 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53187 | 0.010 |
Why?
|
| Male | 4 | 2018 | 349538 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16331 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77478 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 213127 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 213712 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 40450 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 56350 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 85649 | 0.000 |
Why?
|
| Female | 1 | 2018 | 379592 | 0.000 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_